Therefore, we used multiparameter flow cytometry to examine the expression of T cell subsets, including CD62L+ T cells expressing markers of activation, Tregs, and immune checkpoint markers, as well as cytotoxic CD8+ T cells in severe and non-severe hospitalized COVID-19 patients, including patients with chronic illnesses such as diabetes and hypertension. The gene discussed is CD8A; the disease is diabetes mellitus.